El año 2024 fue especialmente difícil para la infancia. Los conflictos cada vez más violentos, las conmociones climáticas y la pobreza provocaron un aumento drástico de las necesidades de los niños y niñas, justo cuando los recursos necesarios para atenderlas se reducían de forma constante. ...
Pese a todo, tal como muestra este Informe anual, UNICEF mantuvo su presencia en más de 190 países y territorios, donde protegió y salvó la vida a millones de niños y niñas incluso en los lugares más remotos. En colaboración con nuestros aliados, suministramos agua salubre e instalaciones de saneamiento, brindamos protección y apoyo psicosocial y prestamos servicios de salud, nutrición, inmunización, educación y capacitación.
En 2025, el panorama mundial sigue estando presidido por cambios políticos importantes, volatilidad, incertidumbre económica y crisis humanitarias cada vez más graves. Si queremos rendir frutos, UNICEF debe dar lo mejor de sí.
Pero los recortes en la financiación –los que ya se han anunciado y los que hay previstos– están limitando la capacidad de UNICEF para llegar a millones de niños y niñas en situación de extrema necesidad. Estos nuevos recortes están generando una crisis mundial de financiación que pondrá en peligro la vida de millones de niños y niñas más.
more
Malaria is a leading cause of illness and death in the developing world and a significant drag on economic development.
This course will provide basic knowledge about the burden of malaria and effective tools to both treat and prevent malaria, and discuss the challenges and opportunities for taking... these interventions to scale.
more
Le paludisme, maladie parasitaire causée par le Plasmodium et transmise par les moustiques Anopheles, reste la première endémie parasitaire mondiale. Malgré une baisse significative de l’incidence et de la mortalité entre 2000 et 2013, grâce aux moustiquaires, aux traitements ACT et aux test...s rapides, la maladie continue de représenter un lourd fardeau pour les pays d’endémie, en particulier en Afrique subsaharienne. En 2013, on estimait encore à 198 millions le nombre de cas et à 584 000 le nombre de décès, principalement touchant les jeunes enfants. La lutte contre le paludisme est un objectif majeur de santé publique mondiale, soutenu notamment par le Fonds mondial. Le paludisme représente aussi un risque non négligeable pour les voyageurs, avec plus de 4 000 cas d’importation en France en 2014. L’absence de vaccin efficace et l’augmentation des résistances rendent la prévention de plus en plus difficile.
more
The WHO recommends parenteral artesunate over quinine and artemether for treating severe Plasmodium falciparum malaria in adults and children. Intravenous administration is preferred. A new one-step, arginine-based formulation eliminates the need for dilution steps, reducing errors and accelerating ...the initiation of treatment—a critical factor for survival. This formulation was first prequalified by the WHO in 2023. By contrast, the conventional two-step artesunate formulation, which was prequalified in 2010, requires more complex preparation. Clear guidance is essential, as product-specific protocols differ. These training materials aim to support the correct and effective administration of the medication.
Accessed on 27/06/2025.
more
Mozambique was the first country outside of the Sahel to successfully implement seasonal malaria chemoprevention (SMC) on a large scale. This learning paper captures some of the lessons drawn from the implementation process.
Moçambique foi o primeiro país fora da região do Sahel a expandir com sucesso a quimioprevenção sazonal da malária (QSM). Neste documento de aprendizagem, descrevemos as lições decorrentes da aplicação em larga escala da QSM em Moçambique.
Lancet Glob Health 2020 Published Online October 22, 2020 https://doi.org/10.1016/S2214-109X(20)30325-9
Where malaria transmission is seasonal, notably in Africa’s Sahel region, children of all ages most at risk of severe malaria are protected through SMC. This intervention consists of full antimalarial treatment courses of sulfadoxine-pyrimethamine and amodiaquine (SPAQ), administered monthly (28 d...ays) during the high-transmission period (typically the rainy season), generally for up to five months per year. SMC can be deployed relatively easily across a large population and is highly cost-effective at only USD $0.30-0.40/dose,3 making it an important tool for malaria control
more
Report of a virtual meeting 21–23 June 2022
WHO has updated it recommendations for 3 key malaria prevention strategies: seasonal malaria chemoprevention (SMC), perennial malaria chemoprevention (PMC – previously known as intermittent preventive treatment in infants, or IPTi) and intermittent preventive treatment of malaria in pregnancy (IPT...p). When given to the young children and pregnant women who are most vulnerable to malaria, preventive chemotherapy has been shown to be a safe, effective and cost-effective strategy for reducing the disease burden and saving lives.
The updated recommendations on SMC, PMC and IPTp, published today in the WHO Guidelines for malaria, will support the broader use of chemoprevention among young children at high risk of severe malaria in areas with both seasonal and year-round transmission and promote expanded access to preventive chemotherapy in pregnancy.
more
This second edition of the Basic Malaria Microscopy package is a stand-alone product,
providing all that is needed to conduct a complete training course
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic ana...emia and increased morbidity and mortality. In addition to diagnostic tools that can detect the acute, blood-stage of P. vivax, new tools are needed to detect the dormant infections before they reactivate and contribute to morbidity and onwards transmission
more
Determination of Parasitemia and Lifecycle
Infection and Drug Resistance 2020:13 4047–4060
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance. ...In 2015, WHO launched the External Quality Assessment scheme for nucleic acid amplification testing to ensure reliable lab results. Coordinated by WHO and operated by the United Kingdom National External Quality Assessment Service for Parasitology, the scheme provides quality-controlled specimens and reports to help improve testing accuracy. Experts recently discussed expanding the scheme to include antimalarial resistance markers.
more
Meeting report, Kampala, Uganda,
7–8 November 2023
Launch of the WHO Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010–2019). Key findings
The Health Communication Capacity Collaborative (HC3) aims to empower organisations to design, implement and evaluate social and behavioural change communication (SBCC) initiatives independently. To this end, it offers a variety of resources, such as the Health COMpass library, SBCC Implementation K...its (I-Kits), online courses, webinars and the Springboard networking platform. These resources support the development of professionals and the implementation of effective health communication strategies across various global health topics.
more